Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC)

Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC)

Thursday May 16, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss Keytruda's approval in renal cell carcinoma (RCC).

Featured Videos

Nikhil Munshi, MD, tells us about the outcomes of the CARTITUDE-1 study from ASH 2019

Noa Biran, MD, tells us about the outcomes of the CARTITUDE-1 study

James Essell, MD, discusses the integration of stem cell transplantation in the treatment of myeloma